These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 18287589

  • 41. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
    Stillman MJ, Stillman MT.
    Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
    [Abstract] [Full Text] [Related]

  • 42. What price pain relief?
    Hochman JS, Shah NR.
    Circulation; 2006 Jun 27; 113(25):2868-70. PubMed ID: 16785335
    [No Abstract] [Full Text] [Related]

  • 43. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK, Abraham NS, Scheiman JM, Laine L, First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Am J Gastroenterol; 2008 Nov 27; 103(11):2908-18. PubMed ID: 18853980
    [Abstract] [Full Text] [Related]

  • 44. Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications.
    Klasser GD, Epstein J.
    J Can Dent Assoc; 2005 Sep 27; 71(8):575-80. PubMed ID: 16202197
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs.
    Patrono C.
    Curr Cardiol Rep; 2016 Mar 27; 18(3):25. PubMed ID: 26841787
    [Abstract] [Full Text] [Related]

  • 48. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S, Santucci L, Distrutti E.
    Dig Liver Dis; 2007 Dec 27; 39(12):1043-51. PubMed ID: 17997373
    [Abstract] [Full Text] [Related]

  • 49. [Study results of routine clinical practice. Do rheumatism patients get substandard care?].
    MMW Fortschr Med; 2005 Nov 24; 147(47):63. PubMed ID: 16370199
    [No Abstract] [Full Text] [Related]

  • 50. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?
    Lazzaroni M, Battocchia A, Bianchi Porro G.
    Dig Liver Dis; 2007 Jun 24; 39(6):589-96. PubMed ID: 17459794
    [Abstract] [Full Text] [Related]

  • 51. Diclofenac use and cardiovascular risks: series of nationwide cohort studies.
    Schmidt M, Sørensen HT, Pedersen L.
    BMJ; 2018 Sep 04; 362():k3426. PubMed ID: 30181258
    [Abstract] [Full Text] [Related]

  • 52. [Chemoprevention of colorectal cancer].
    Stelmaszuk T, Jałocha L, Wojtuń S, Gil J.
    Pol Merkur Lekarski; 2009 May 04; 26(155):565-8. PubMed ID: 19606728
    [Abstract] [Full Text] [Related]

  • 53. Effect of dosage on coxib- or nonsteroidal antiinflammatory drug-associated cardiovascular risk? Comment on the article by Solomon et al.
    Boers M.
    Arthritis Rheum; 2007 Jan 04; 56(1):384; author reply 384. PubMed ID: 17195242
    [No Abstract] [Full Text] [Related]

  • 54. Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.
    Hinz B, Renner B, Brune K.
    Nat Clin Pract Rheumatol; 2007 Oct 04; 3(10):552-60; quiz 1 p following 589. PubMed ID: 17906610
    [Abstract] [Full Text] [Related]

  • 55. The murky waters of the coxibs: a review of the current state of play.
    Ostor AJ, Hazleman BL.
    Inflammopharmacology; 2005 Oct 04; 13(4):371-80. PubMed ID: 16354390
    [Abstract] [Full Text] [Related]

  • 56. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS, Abdul-Hadi O, Parvizi J, Viscusi ER, Einhorn T.
    Instr Course Lect; 2009 Oct 04; 58():759-68. PubMed ID: 19385584
    [Abstract] [Full Text] [Related]

  • 57. Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?
    Spektor G, Fuster V.
    Nat Clin Pract Cardiovasc Med; 2005 Jun 04; 2(6):290-300. PubMed ID: 16265533
    [Abstract] [Full Text] [Related]

  • 58. [Cardiovascular toxicity of selective COX-2-inhibitors and classical NSAIDs].
    Lange H, Eberhart L.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Jul 04; 42(7):514-7. PubMed ID: 17661262
    [Abstract] [Full Text] [Related]

  • 59. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
    Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD.
    Aliment Pharmacol Ther; 2008 Nov 15; 28(10):1249-58. PubMed ID: 18729848
    [Abstract] [Full Text] [Related]

  • 60. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study.
    Fosbøl EL, Gislason GH, Jacobsen S, Folke F, Hansen ML, Schramm TK, Sørensen R, Rasmussen JN, Andersen SS, Abildstrom SZ, Traerup J, Poulsen HE, Rasmussen S, Køber L, Torp-Pedersen C.
    Clin Pharmacol Ther; 2009 Feb 15; 85(2):190-7. PubMed ID: 18987620
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.